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Summary Dengue infection is a mosquito-borne disease caused by a flavivirus, and is recog-
nized in over 100 countries with 2.5 billion people living in areas of risk. Neurological manifesta-
tions such as encephalitis, myelitis, Guillain—Barre´ syndrome, cranial nerve palsies,
neuromyelitis optica, and encephalomyelitis have been recognized as clinical consequences
of dengue infection. Meningitis is a rare complication. We report the case of a 24-year-old woman
who presented with fever, headache, and nuchal rigidity without the typical symptoms of dengue
infection. Cerebrospinal fluid analysis showed lymphocytic pleocytosis with a normal glucose
value and negative bacterial and fungal cultures. The etiology of meningitis was confirmed by
positive dengue PCR in the serum. This case report highlights dengue infection as a potential
cause of meningitis in endemic areas. Also, meningitis can be the first manifestation of the
infection. Dengue should be investigated even in the absence of a typical picture of the infection.
# 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Dengue infection is caused by a flavivirus, and is recognized
as one of the most important mosquito-borne human infec-
tions of the 21st century.1 The number of cases has increased
enormously, arising from more than 100 tropical and sub-* Corresponding author. Tel.: +55 21 3208 2084;
fax: +55 21 9852 4686.
E-mail address: cnsoares@predialnet.com.br (C.N. Soares).
1201-9712/$36.00 # 2009 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2009.03.016tropical countries of the world, with 2.5 billion people living
in areas of risk.2 Dengue virus type 3 (DENV-3) was isolated in
Brazil for the first time in December 2000. During the DENV-3
epidemic of 2002, the number of dengue hemorrhagic fever
(DHF)/dengue shock syndrome (DSS) cases and deaths
exceeded the number of these cases caused by other ser-
otypes of dengue virus in other epidemics.3 This virus type is
also more related to neurovirulence.4
Several neurological manifestations have been described
each year, however the prevalence of neurological manifes-
tations is unknown. Atypical neurological complications havePublished by Elsevier Ltd. All rights reserved.
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neuromyelitis optica,6 and Guillain—Barre´ syndrome, the last
one with poor or without dengue infection signs before the
neurological picture.7 Encephalitis is the most common neu-
rological manifestation associated with dengue infection.
Unlike other viral infections, meningitis determined by den-
gue infection is a rare complication.8
We describe a case of meningitis caused by an oligosymp-
tomatic dengue infection that occurred during the dengue
epidemic of 2007—2008, in the city of Rio de Janeiro, Brazil.
Case report
A 24-year-old woman complained of a frontal, throbbing
headache, refractory to analgesic drugs. One day after the
onset of pain, she developed fever and vomiting. The symp-
toms remained for four days. There was no myalgia, joint
pain, bleeding, diarrhea, cutaneous rash, or past history of
dengue. A neurological examination was normal, except for
the presence of nuchal rigidity +/4 + . Hemogram/platelet
count and biochemistry were normal. A brain computed
tomography scan did not show any abnormalities. Cerebrosp-
inal fluid (CSF) was collected by lumbar puncture on the
fourth day of symptoms and showed 362  106 cells/l (66% of
lymphocytes), glucose of 86 mg/dl, and total protein of
144 mg/dl. On analysis of the CSF, bacterial/fungal cultures
and immunological testing for syphilis (VDRL) were negative,
as well as human T-lymphotropic virus I (HTLV-I), herpes
simplex virus (HSV), varicella zoster virus, cytomegalovirus
(CMV), and HIV1/2 antibodies (by ELISA). During hospitaliza-
tion the serum and CSF were dengue IgM and IgG antibody
negative (ELISA, Panbio, Australia). PCR for dengue was
positive in the serum, for virus type 3. This was performed
using a reverse transcriptase-PCR (RT-PCR) following the
procedure described by Kumaria and Chakravarti9
(Figure 1). PCR for HSV, CMV, and enterovirus were negative.Figure 1 Dengue type 3 detection by RT-PCR. Lane 1, molecular st
dengue 3 control; lane 4, positive dengue 2 control; lane 5, negativAfter analgesic treatment and venous hydration, the
patient’s symptoms disappeared completely.
Discussion
Our case occurred during the dengue epidemic of 2007—2008
and did not have the typical infection symptoms of dengue.
There was no history of muscle pain, diarrhea, joint or
abdominal pain, petechiae or purpura, thrombocytopenia,
rash, or bleeding. The main symptom was the severe head-
ache, which was refractory to analgesics and throbbing,
determining hospitalization. According to the literature,10
headache is described as extremely severe in 51.8% of
dengue cases and severe in 27.1%. However, CSF analysis
is not used as a routine exam to differentiate a common
dengue headache from meningitis. This fact makes dengue
meningitis underestimated. Our case, besides the intense
headache, also presented nuchal rigidity, suggesting a
meningeal involvement.
To our knowledge, there have been no other descriptions
of meningitis caused by dengue virus type 3 infection, since
only dengue encephalitis has been reported. This is the first
description of the disease in adults, confirmed by PCR. The
hypothesis of meningismus was discarded, since the CSF
sample showed active inflammation, characterized by pleo-
cytosis and hyperproteinorachia. Although the virus was not
found in the CSF, its presence in the serum confirms the
diagnosis. Dengue PCR has a sensitivity of 98—99% and a
specificity of 100% in serum during the first five days of
symptoms.11 The pathogenesis of dengue in the central
nervous system is still unknown. As a hypothesis, the virus
would invade the central nervous system. The breakdown of
the blood—brain barrier during dengue infection in mice,
determining virus invasion, was demonstrated by Chaturvedi
et al.12 However, the sensitivity and specificity of the PCR
technique for the CSF have not been established. Hence, aandard; lane 2, patient sample (dengue type 3); lane 3, positive
e control.
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detected. The negativity of dengue IgM antibody was
expected because the blood and CSF samples were collected
before the seventh day after the onset of symptoms. Dengue
IgM antibody can appear, in half of the patients, within 2—3
days of defervescence.13
Other causes of viral meningitis, mainly that as a result of
enteroviruses, should be investigated in the differential
diagnosis. Enteroviruses are responsible for 85% of viral
meningitis cases, being usually benign and associated
with a broad range of diseases, from an undifferentiated
febrile illness to distinct clinical syndromes (herpangina,
hand-foot-mouth syndrome, and pleurodynia).14 Our case
had non-specific clinical characteristics and the enterovirus
diagnosis could only be discarded by the negative PCR test.
In conclusion, our report demonstrates that CSF analysis is
necessary to differentiate headache due to systemic infec-
tion from that due to meningitis. In addition, meningitis can
be the first manifestation of dengue infection. In endemic
areas, dengue infection should be suggested and tested as a
probable etiological agent of meningitis.
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